Dallas Fort Worth Injury Lawyer Blog

July 14, 2012

DePuy ASR & Pinnacle Metal Hip Failure Problems

As DePuy ASR and DePuy Pinnacle metal on metal hip failure and replacement attorney, I have written extensively about the inherent early failure problems associated with metal on metal hips like the DePuy ASR, Pinnacle hip replacement models and others made by Biomet (Biomet M2a Magnum), Zimmer, Smith and Nephew and Wright (Conserve and ProFemur).

Johnson & Johnson faces more damaging and costly sequel to the $3 billion recall of its ASR all-metal artificial hips in August of 2010. The DePuy ASR recall was one of the most expensive medical device failures in U.S. history.

There are 1,600 lawsuits pending in U.S. District Court for the Northern District of Texas, centralized in Dallas. The Pinnacle metal-on-metal hip system is also manufactured by Johnson & Johnson.

July 14, 2012

Hair Raising Side Effects of Propecia

by Dr. Shezad Malik

As a Dallas Texas Defective Drug attorney, I have written extensively about the side effects of many commonly used drugs. More recently attention as been directed at PROPECIA.

What is Propecia?

Propecia (finasteride) is a prescription medication that is marketed to help restore natural hair loss that occurs in some men. However, side effects of Propecia have been linked to sexual problems for some users, including reports of erectile dysfunction, decreased libido, genital shrinkage and problems with cognition. These issues have also been linked to severe depression and at least one man has reportedly committed suicide due to the Propecia problems.

July 11, 2012

Yaz Blood Clot Settlements Progressing

by Dr. Shezad Malik

As a Yaz Pulmonary Embolism, Deep Vein Thrombosis Attorney I have written extensively about the risks inherent in birth control pills containing Drospirenone.

According to status report held on June 22, in the U.S. District Court for the Southern District of Illinois, Bayer has reached agreements with about 33 different law firms to resolve at least 1,444 YAZ Deep Vein Thrombosis, Stroke and Pulmonary Embolism claims.

According to Bloomberg News, as of late April, Bayer faced 11,900 lawsuits over Yaz and its sister drug Yasmin in the U.S. with about 14,000 plaintiffs. Experts predict that the company may have to pay up to $2.65 billion to settle all of the pending cases.

July 9, 2012

Biomet M2a Hip Lawsuits MDL Consolidation Pending

by Dr. Shezad Malik

As Biomet M2a Magnum metal on metal hip replacement attorney, I have written extensively about the inherent early failure problems associated with metal on metal hips like the DePuy ASR, Pinnacle hip replacement models and others made by Biomet, Zimmer, Smith and Nephew and Wright.

In recent years, concerns have emerged about the safety of all metal-on-metal hip replacement systems. The metal-on-metal design causes cobalt and chromium metallic microscopic shards to shear off from the metallic articular surfaces through the grinding wear and tear mechanism. The articular surfaces involve the metallic surfaces of the acetabular cup, femoral head and taper sleeve.

There is mounting evidence of the significant risks that the patients are exposed to; including premature device failure, osteolysis (bone loss), bone and tissue damage, metallosis (metal poisoning) and heavy metal toxicity.

July 7, 2012

Actos Bladder Cancer Side Effects Detailed in Canadian Study

by Dr. Shezad Malik

As an Actos Bladder Cancer attorney I have written extensively of the alleged injuries of bladder cancer with the use of the newer diabetic drug, Actos. A recent Canadian mega study has linked the dangerous life threatening side effects of Actos to an increased risk of bladder cancer. According to medical researchers there is an association between the Actos and bladder cancer. This research was published in this month issue of the Canadian Medical Journal.

Thiazolidinediones, especially Actos (pioglitazone), may increase the risk of bladder cancer. The researchers conducted a systematic review and meta-analysis to evaluate the risk of bladder cancer among adults with type 2 diabetes taking thiazolidinediones.The study found that there is a 22% increased risk of bladder cancer among patients with type 2 diabetes using Actos or another drug belonging to the same class of medications, known as thiazolidinediones.

Other Studies Confirming Link between Actos and Bladder Cancer

July 6, 2012

Accutane Inflammatory Bowel Trial Roche Ordered to Pay $18M

by Dr. Shezad Malik

As an Accutane Inflammatory Bowel Side Effect attorney, I have written extensively about the risks of Crohn’s Disease and Ulcerative Colitis associated with the use of Accutane. Now according to a New Jersey jury, an Accutane trial in New Jersey state court has resulted in a verdict of $18 million.

Accutane, is an acne medication developed and manufactured by Roche. Roche Holding AG (ROG) must pay a total of $18 million in personal injury and product liability damages to two users of its Accutane acne drug who blamed the medicine for their inflammatory bowel disease.

Jurors found that Roche failed to properly warn Kathleen Rossitto and Riley Wilkinson that Accutane could cause inflammatory bowel disease.

July 3, 2012

Actos Bladder Cancer Injury and Death Update

by Dr. Shezad Malik

As an Actos Bladder Cancer attorney I have written extensively of the alleged injuries of bladder cancer with the use of the newer diabetic drug, Actos. A Virginia man has filed lawsuit alleging that he took Actos and developed bladder cancer. The suit was filed in the U.S. District Court for the Western District of Louisiana on June 14th (Case No. 6:12-cv-1704). The case is one of many pending in the Actos multidistrict litigation (MDL No. 6:11-md-2299).

What is Actos?

Actos is a type 2 diabetes medication that has been on the US market since 1999. It is manufactured by Takeda Pharmaceuticals. Actos is one of Takeda’s top-selling drugs with global sales of $4.8 billion last year; in 2008, Actos was the 10th best -selling medication in the United States.

July 2, 2012

FDA: No Use for Metal-on-Metal Hips

by Dr. Shezad Malik

As a DePuy ASR Recall and DePuy Pinnacle Replacement attorney, I have written extensively about the inherent problems associated with metal on metal hips like the DePuy ASR, Pinnacle hip relacement models and others made by Biomet, Zimmer, Smith and Nephew and Wright.

According to the FDA health experts there is no compelling reason to continue using metal-on-metal hip implants. There is overwhelming and mounting evidence that these metal on metal devices can break down early and expose patients to dangerous metallic particles, a condition known as metallosis.

FDA Expert Panel Report

June 30, 2012

NuvaRing Heart Attack, Stroke, DVT and Pulmonary Embolism Risk

by Dr. Shezad Malik

As a NuvaRing Pulmonary Embolism, Deep Vein Thrombosis Attorney I have written extensively about the risks inherent in birth control pills containing Drospirenone and NuvaRing.

I recently gave an interview to an online magazine, reprinted below, click here for full article.

Two recently published studies suggest that the risk of NuvaRing side effects may be higher than women were led to believe. Dr. Shezad Malik, cardiologist and founder of the Dr. Shezad Malik Law Firm says Merck, the maker of NuvaRing contraceptive did not adequately warn about the risks associated with the device. NuvaRing lawsuits have now been filed, alleging some women suffered venous thrombo-embolism including deep vein thrombosis, pulmonary embolism and heart attack or stroke after using the birth control ring.

June 28, 2012

Beyaz Pulmonary Embolism Injury Attorney

by Dr. Shezad Malik

As a Yaz, Yasmin and Ocella pulmonary embolism attorney, I have written extensively about the venous thrombo-embolism (VTE) side effects from Drospirenone containg oral contraceptive pills.

Beyaz is an oral contraceptive approved by the FDA in 2010, that contains folate (0.451 mg of levomefolate calcium). It is a “fourth generation” form of birth control that contains drospirenone, a new type of synthetic progestin. Drospirenone has been linked to potentially deadly side effects, including pulmonary embolism (PE), Deep Vein Thrombosis and Stroke.

What is Beyaz?